ConductScience.org, home
Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease
API referenceFor AI assistants

Trial · NCT00975195

Results by group138

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 138

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Time to First Moderate or Severe On-treatment COPD ExacerbationFluticasone Maintenance107.095% Confidence Interval 94.0 to 124.0days
Time to First Moderate or Severe On-treatment COPD ExacerbationFluticasone Withdrawal110.095% Confidence Interval 99.0 to 120.0days
Number of Moderate or Severe On-treatment COPD ExacerbationsFluticasone Maintenance0.9195% Confidence Interval 0.83 to 0.99exacerbations per patient-year
Number of Moderate or Severe On-treatment COPD ExacerbationsFluticasone Withdrawal0.9595% Confidence Interval 0.87 to 1.04exacerbations per patient-year
Proportion of Patients With ≥1 Moderate or Severe On-treatment COPD ExacerbationFluticasone Maintenance44.2percentage of participants
Proportion of Patients With ≥1 Moderate or Severe On-treatment COPD ExacerbationFluticasone Withdrawal46.7percentage of participants
Time to First Severe On-treatment COPD ExacerbationFluticasone MaintenanceNA95% Confidence Interval NA to NAdays
Time to First Severe On-treatment COPD ExacerbationFluticasone Withdrawal419.095% Confidence Interval 379.0 to NAdays
Number of Severe On-treatment COPD ExacerbationsFluticasone Maintenance0.2095% Confidence Interval 0.17 to 0.23exacerbations per patient-year
Number of Severe On-treatment COPD ExacerbationsFluticasone Withdrawal0.2395% Confidence Interval 0.19 to 0.27exacerbations per patient-year
Proportion of Patients With at Least One Severe On-treatment COPD Exacerbation.Fluticasone Maintenance13.4percentage of participants
Proportion of Patients With at Least One Severe On-treatment COPD Exacerbation.Fluticasone Withdrawal15.2percentage of participants
Time to First On-treatment COPD ExacerbationFluticasone Maintenance365.095% Confidence Interval 309.0 to NAdays
Time to First On-treatment COPD ExacerbationFluticasone Withdrawal346.095% Confidence Interval 302.0 to NAdays
Number of On-treatment COPD ExacerbationsFluticasone Maintenance1.0395% Confidence Interval 0.95 to 1.12exacerbations per patient-year
Number of On-treatment COPD ExacerbationsFluticasone Withdrawal1.0895% Confidence Interval 0.99 to 1.17exacerbations per patient-year
Proportion of Patients With at Least One On-treatment COPD ExacerbationFluticasone Maintenance46.9percentage of participants
Proportion of Patients With at Least One On-treatment COPD ExacerbationFluticasone Withdrawal49.0percentage of participants
Severity of On-treatment COPD ExacerbationsFluticasone MaintenanceNone and patient completed randomised treatment42.9percentage of participants
Severity of On-treatment COPD ExacerbationsFluticasone WithdrawalNone and patient completed randomised treatment41.2percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00975195/results

API referenceFor AI assistants